Patent · US Active

Thia-triaza-indacenes

US9243000B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Lars Van Der Veen · Wien, AT
Darryl McConnell · Wien, AT
Siegfried Schneider · Wien, AT
Matthias Grauert · Ingelheim am Rhein, DE
Andreas Schoop · Wien, AT
Tobias Wunberg · Mödling, AT

Key dates

Filing date	Apr 22, 2010
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Jul 20, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.